Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis.
Xiangming CaiJunhao ZhuJin YangChao TangZixiang CongChiyuan MaPublished in: Chinese neurosurgical journal (2022)
For patients with clear indications or contraindications for surgery, choosing surgery or DAs accordingly is unequivocal. However, for patients with clinical equipoise, such as surgery, especially endoscopic surgery, in microprolactinoma and macroprolactinoma patients, we suggest that neurosurgeons and endocrinologists conduct high-quality clinical trials to address the clinical equipoise quantitatively.
Keyphrases
- minimally invasive
- coronary artery bypass
- clinical trial
- surgical site infection
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- randomized controlled trial
- rheumatoid arthritis
- prognostic factors
- disease activity
- combination therapy
- patient reported
- phase ii
- phase iii